# Helsinn Therapeutics

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/helsinn-therapeutics/

## Facts

| Field | Value |
| --- | --- |
| Country | US |
| Description | company in Iselin, United States |
| OpenAlex ID | https://openalex.org/F4320332631 |
| ROR ID | https://ror.org/05xfrjs60 |
| Works | 132 |

## Funder papers

- [Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical Outcomes](https://scholariq.org/papers/concurrent-rb1-and-tp53-alterations-define-a-subset-of-egfr-mutant-lung-cancers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.